The initiative covers medications required in chemotherapy, targeted therapy, supportive care, as well as antibiotics, antifungals, and at least 260 other drugs. The cost reduction is expected to be substantial, not only reducing out-of-pocket expenses for patients but also freeing up hospital funds for other critical initiatives